Search research articles
Contact Us
Filters
Showing results (211-220 of 245) with videos related to
Page
of 25
Sort By:
Biophysical Journal
|
July 16, 2018
Dynamics of Dystrophin's Actin-Binding Domain
Michael E Fealey, Benjamin Horn, Christian Coffman, et al.
Scientific Reports
|
August 24, 2018
Targeting protein-protein interactions for therapeutic discovery via FRET-based high-throughput screening in living cells
Daniel R Stroik, Samantha L Yuen, Kevyn A Janicek, et al.
Biophysical Journal
|
November 25, 2014
FRET-based trilateration of probes bound within functional ryanodine receptors
Bengt Svensson, Tetsuro Oda, Florentin R Nitu, et al.
The Journal of Biological Chemistry
|
December 7, 2018
Converter domain mutations in myosin alter structural kinetics and motor function
Laura K Gunther, John A Rohde, Wanjian Tang, et al.
Research Square
|
March 13, 2023
FRET assay for live-cell high-throughput screening of the cardiac SERCA pump yields multiple classes of small-molecule allosteric modulators
Osha Roopnarine, Samantha L Yuen, Andrew R Thompson, et al.
Biorxiv : the Preprint Server for Biology
|
March 3, 2023
FRET assay for live-cell high-throughput screening of the cardiac SERCA pump yields multiple classes of small-molecule allosteric modulators
Osha Roopnarine, Samantha L Yuen, Andrew R Thompson, et al.
The Journal of Biological Chemistry
|
April 13, 2012
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) induces death receptor 5 networks that are highly organized
Christopher C Valley, Andrew K Lewis, Deepti J Mudaliar, et al.
Elife
|
May 12, 2021
Structural basis for allosteric control of the SERCA-Phospholamban membrane complex by Ca<sup>2+</sup> and phosphorylation
Daniel K Weber, U Venkateswara Reddy, Songlin Wang, et al.
The Journal of Biological Chemistry
|
November 13, 2022
Enhancing interaction of actin and actin-binding domain 1 of dystrophin with modulators: Toward improved gene therapy for Duchenne muscular dystrophy
Piyali Guhathakurta, Anna L Carter, Andrew R Thompson, et al.
The Journal of Biological Chemistry
|
February 2, 2023
Early-phase drug discovery of β-III-spectrin actin-binding modulators for treatment of spinocerebellar ataxia type 5
Piyali Guhathakurta, Robyn T Rebbeck, Sarah A Denha, et al.
Page
of 25
Search research articles
Search
Showing results (211-220 of 245) with videos related to
Sort By:
Page
of 25
Biophysical Journal
|
July 16, 2018
Dynamics of Dystrophin's Actin-Binding Domain
Michael E Fealey, Benjamin Horn, Christian Coffman, et al.
Scientific Reports
|
August 24, 2018
Targeting protein-protein interactions for therapeutic discovery via FRET-based high-throughput screening in living cells
Daniel R Stroik, Samantha L Yuen, Kevyn A Janicek, et al.
Biophysical Journal
|
November 25, 2014
FRET-based trilateration of probes bound within functional ryanodine receptors
Bengt Svensson, Tetsuro Oda, Florentin R Nitu, et al.
The Journal of Biological Chemistry
|
December 7, 2018
Converter domain mutations in myosin alter structural kinetics and motor function
Laura K Gunther, John A Rohde, Wanjian Tang, et al.
Research Square
|
March 13, 2023
FRET assay for live-cell high-throughput screening of the cardiac SERCA pump yields multiple classes of small-molecule allosteric modulators
Osha Roopnarine, Samantha L Yuen, Andrew R Thompson, et al.
Biorxiv : the Preprint Server for Biology
|
March 3, 2023
FRET assay for live-cell high-throughput screening of the cardiac SERCA pump yields multiple classes of small-molecule allosteric modulators
Osha Roopnarine, Samantha L Yuen, Andrew R Thompson, et al.
The Journal of Biological Chemistry
|
April 13, 2012
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) induces death receptor 5 networks that are highly organized
Christopher C Valley, Andrew K Lewis, Deepti J Mudaliar, et al.
Elife
|
May 12, 2021
Structural basis for allosteric control of the SERCA-Phospholamban membrane complex by Ca<sup>2+</sup> and phosphorylation
Daniel K Weber, U Venkateswara Reddy, Songlin Wang, et al.
The Journal of Biological Chemistry
|
November 13, 2022
Enhancing interaction of actin and actin-binding domain 1 of dystrophin with modulators: Toward improved gene therapy for Duchenne muscular dystrophy
Piyali Guhathakurta, Anna L Carter, Andrew R Thompson, et al.
The Journal of Biological Chemistry
|
February 2, 2023
Early-phase drug discovery of β-III-spectrin actin-binding modulators for treatment of spinocerebellar ataxia type 5
Piyali Guhathakurta, Robyn T Rebbeck, Sarah A Denha, et al.
Page
of 25